Our results showed no significant effect of the pharmacological inhibition of the PGD2 receptors DP1 and DP2 on the facilitated symptoms of psoriasis observed in the IMQ-treated mPGES-1−/− mice (Fig. S3). This evidence concerns the gene PTGDR and psoriasis.